Sungjin Park

Sungjin Park

Company: Onegene Biotechnology

Job title: ceo


Unlocking Powerful Biology: OGB21502 is a Tetra- Specific Drug (GLP-1 X GCG X FGF21 X IL1RA) to Treat NASH & Liver Fibrosis 11:30 am

Novel protein-protein conjugation technology, which enables the facile development of multi-modalities, multi-targeting drugs Can IL-1 blocking make synergy in improving fibrosis and metabolism? Preclinical findings recommend transitioning towards the clinical stage in 2024Read more

day: Seminar A- AM tracks

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.